A CTLA4 lesson...and the logic to add IPI to combos | IDRA Message Board Posts

Idera Pharmaceuticals, Inc

  IDRA website

IDRA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1503 of 1620  at  8/14/2019 11:08:54 PM  by

raferjack


 In response to msg 1501 by  vorlon1966
view thread

Re: A CTLA4 lesson...and the logic to add IPI to combos

IDRA will soon start recruiting patients with SCCHN and MSS CRC for combination therapy with Tilsotolimod (IMO-2125) + Ipi + Nivo in collaboration with BMS.
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 126
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...